Nomogram predicting recurrence and melanoma-specific mortality in patients - Evidencio
Nomogram predicting recurrence and melanoma-specific mortality in patients with negative sentinel lymph nodes
This validated model estimates the 5-year risk of recurrence and melanoma-specific mortality in melanoma patients with negative sentinel lymph nodes (c-index for the recurrence model was 0.74 and 0.76 for the calibrated model for melanoma-specific mortality).

The model is not appropriate for melanoma patients who did not undergo sentinel lymph node biopsy or those who have positive sentinel lymph nodes. 
Research authors: D. Verver, D. van Klaveren, V. Franke, A.C.J. van Akkooi, P. Rutkowski, U. Keilholz, A.M.M. Eggermont, T. Nijsten, D.J. Grunhagen, C. Verhoef, A. Rekkas (online model)
Version: 1.18
  • Public
  • Oncology
  • {{ modelType }}
  • Details
  • Save input
  • Load input
Display
Units

Calculate the result

Set more parameters to perform the calculation
Calculating......
Calculation error. Please check the algorithm..

Conditional information

{{ file.classification }}
PRO
Note
Notes are only visible in the result download and will not be saved by Evidencio

This algorithm is provided for educational, training and information purposes. It must not be used to support medical decision making, or to provide medical or diagnostic services. Read our full Disclaimer.

Underlying algorithms Part of
Comments
Comment
Please enter a comment
Comments are visible to anyone

Algorithm feedback

No feedback yet 1 Comment {{ model.comments.length }} Comments
On {{ comment.created_at }} {{ comment.user.username }} a no longer registered author wrote:
{{ comment.content }}
Evidencio v3.35 © 2015 - 2025 Evidencio. All Rights Reserved